- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT04439019
Group Education & Lifestyle Modification's Impact on Weight Loss & Quality Life of Patients With OA
Group Education and Digitally Delivered Lifestyle Modification Program to Enable Weight Loss and Improve Metabolic Health and Quality of Life for Patients With Osteoarthritis and Overweight/Obesity.
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
Obesity, osteoarthritis, and metabolic syndrome are interrelated diseases. In addition to surgical management, there is the need to identify and provide earlier non-surgical management for individuals with metabolic and body composition changes that are contributing to osteoarthritis progression.
It has been well-established that is a challenge for clinicians to identify and deliver optimal treatment approaches for patients with osteoarthritis and obesity. The long wait times for orthopedic consultation in Alberta present an excellent opportunity to optimize patients with medical comorbidities and can simultaneously improve the pain and disability from their osteoarthritis. This is also an excellent opportunity to involve patients and their families in co-managing their own disease and working towards better health and less pain and disability.
The "OA Optimization Program" has been developed by Dr Berchuk, FRCPC, Diplomat of the American Board of Obesity Medicine. It is a lifestyle and dietary modification program. In cooperation with Calgary's Alberta Hip and Knee Clinic at Gulf Canada Square, Dr Berchuk will offer patients this program while they await orthopedic consultation. This is an optional program offered to all patients. There is an initial group information session for patients who express interest. For those who choose to enroll, the program begins with a medical assessment by Dr Berchuk. The initial consultation consists of a medical assessment which includes medical history and physical examination, a previous dietary history, a readiness for change assessment, and screening for contraindications to the program. The patients will then attend group counselling sessions every 3 months for one year, or until their surgical date. The group counselling will be supplemented by the Grohealth digital therapeutic nutrition program. Participants return for group counselling sessions at Gulf Canada Square clinic every 3 months until orthopedic consultation and if surgery is deemed appropriate, until surgery.
As with any major lifestyle change, peer support is crucial to long term success. Patients are encouraged to bring their family members to the initial consultation and to group sessions. During the group sessions, Dr Berchuk will use techniques to encourage the building of a peer support network, as well as medical cognitive behavior therapy techniques.
Investigators intend to demonstrate that the use of the OA Optimization program can lead to improvement in Quality of Life measures including pain and disability in patients with severe osteoarthritis, as well as improvements in markers of health such as BMI, waist circumference, blood pressure, medication use in diabetic and hypertensive patients, and markers such as serum lipids and markers of inflammation. It is entirely plausible that with preoperative weight loss and/or improvement in metabolic disease, patients may see such dramatic improvement in their symptoms that they choose to postpone surgery.
Research Question and Objectives:
Can the OA Optimization Program lead to improvement in pain and disability related to severe osteoarthritis? Investigators aim to demonstrate that the use of a lifestyle and dietary counselling program can lead to improvements in pain and disability in patients with severe osteoarthritis.
Can the OA Optimization Program demonstrate significant improvements in obesity, hypertension, hyperlipidemia, and glycemic control? Investigators aim to demonstrate improvements in markers of health such as decreased BMI, decreased waist circumference, decreased medication use in diabetic and hypertensive patients, improvement in biomarkers such as serum lipids and serum markers of systemic inflammation.
Typ studiów
Zapisy (Oczekiwany)
Faza
- Nie dotyczy
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Symptomatic osteoarthritis
- BMI ≥ 25
Exclusion Criteria:
- Age < 18
- Currently following a specialized or therapeutic diet
- Pregnant or breastfeeding
- Type 1 Diabetes
- Unable to read or speak English
- Unwilling to use the digital application
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Nie dotyczy
- Model interwencyjny: Zadanie dla jednej grupy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: All patients referred to the Alberta Hip and Knee Clinic
All patients who are diagnosed with severe osteoarthritis undergoing total hip/knee replacement surgery and show interest to be part of the study.
|
The "OA Optimization Program" is a lifestyle and dietary modification program.
All Patients will be offered this optional program while they await orthopedic consultation.
There is an initial group information session for participants followed by medical assessment which includes medical history and physical examination, a previous dietary history, a readiness for change assessment, and screening for contraindications to the program.
The patients will then attend group counselling sessions every 3 months for 1 year, or until their surgical date.Patients are encouraged to attend sessions with a family member.
Improvement in Quality of Life measures including pain and disability in patients with severe osteoarthritis, as well as improvements in markers of health such as BMI, waist circumference, blood pressure, medication use in diabetic and hypertensive patients, and markers such as serum lipids and markers of inflammation will be shown.
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
BMI
Ramy czasowe: every 3 months over 12 months.
|
Change in BMI compared to last visit
|
every 3 months over 12 months.
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Blood pressure
Ramy czasowe: every 3 months over 12 months.
|
Change in blood pressure compared to last visit
|
every 3 months over 12 months.
|
serum lipids and markers of inflammation/ Glycemic acid
Ramy czasowe: every 3 months over 12 months.
|
Change in blood markers compared to last visit
|
every 3 months over 12 months.
|
Health-related quality of life
Ramy czasowe: every 3 months over 12 months.
|
Health-related quality of life as measured by EQ-5D-5L
|
every 3 months over 12 months.
|
Pain and functional limitation
Ramy czasowe: every 3 months over 12 months.
|
Pain and functional limitation as measured by WOMAC
|
every 3 months over 12 months.
|
Medication use
Ramy czasowe: every 3 months over 12 months.
|
Changes in use of diabetic and blood pressure medication
|
every 3 months over 12 months.
|
waist circumference
Ramy czasowe: every 3 months over 12 months.
|
Comparing waist circumference to last visit
|
every 3 months over 12 months.
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Oczekiwany)
Zakończenie podstawowe (Oczekiwany)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- REB19-1814
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Lifestyle and dietary modification program
-
Oxford Biomedical Technologies, Inc.RekrutacyjnyIBS – zespół jelita drażliwegoStany Zjednoczone
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)ZakończonyOtyłość | Czynnik ryzyka sercowo-naczyniowego | Ryzyko cukrzycy
-
VA Office of Research and DevelopmentRekrutacyjnySchizofrenia | Schizoafektywny | Zaburzenie afektywne dwubiegunowe 1Stany Zjednoczone
-
Stanford UniversityNational Institute of Mental Health (NIMH); Washington University School of...ZakończonyZaburzenia odżywianiaStany Zjednoczone
-
Christine Kaiser, LAc, DACMRekrutacyjnyProblemy z płodnościąStany Zjednoczone
-
USDA Grand Forks Human Nutrition Research CenterCalifornia Polytechnic State University-San Luis ObispoZakończonySpożycie owoców i warzyw | Żywienie dzieci | Wybór zdrowej żywności | Przygotowanie zdrowej żywnościStany Zjednoczone
-
University of MiamiNational Institute of Mental Health (NIMH)Zakończony
-
Collinge and Associates, Inc.National Cancer Institute (NCI)Zakończony
-
University of OxfordBeijing Normal University; Beijing Stars and Rain Education Institute for AutismZakończonyPrzemoc wobec dzieci | Relacje rodzic-dziecko | Zaburzenia ze spektrum autyzmu | Rodzicielstwo | Problem z zachowaniem dziecka | Relacje rodzinne | Kwestia zdrowia psychicznegoChiny
-
Haukeland University HospitalUniversity of Bergen; Norwegian University of Science and Technology; St. Olavs... i inni współpracownicyRekrutacyjnyZaburzenia ze spektrum autyzmuNorwegia